Literature DB >> 21518749

Remote monitoring: a cost or an investment?

Haran Burri1, Hein Heidbüchel, Werner Jung, Pedro Brugada.   

Abstract

Remote management of pacemakers and implantable defibrillators is being increasingly used in Europe, due to its potential to improve follow-up efficiency and patient outcome. However, this paradigm shift needs to be economically viable for it to be sustainable in the long term. This article covers the economic aspects of remote device management, and reviews the current evidence in this field.

Entities:  

Mesh：

Year:  2011        PMID： 21518749     DOI： 10.1093/europace/eur082

Source DB:  PubMed          Journal:  Europace        ISSN： 1099-5129            Impact factor:   5.214


  11 in total

1.  Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population.

Authors:  Renato P Ricci; Alfredo Vicentini; Antonio D'Onofrio; Antonio Sagone; Antonio Vincenti; Luigi Padeletti; Loredana Morichelli; Antonio Fusco; Filippo Vecchione; Francesco Lo Presti; Alessandra Denaro; Annalisa Pollastrelli; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2013-09-21       Impact factor: 1.900

2.  Is There a Future for Remote Cardiac Implantable Electronic Device Management?

Authors:  Haran Burri
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-08

Review 3.  EHRA(European Heart Rhythm Association) EP-Wires Surveys: What Is Common Practice In Device Management?

Authors:  Carina Blomström-Lundqvist; Maria G Bongiorni
Journal:  J Atr Fibrillation       Date:  2014-10-31

4.  Cardiac Pacing - Is Telemonitoring Now Essential?

Authors:  Haran Burri
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11

5.  Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study.

Authors:  Leonardo Calò; Alessio Gargaro; Ermenegildo De Ruvo; Gabriele Palozzi; Luigi Sciarra; Marco Rebecchi; Fabrizio Guarracini; Alessandro Fagagnini; Enrico Piroli; Ernesto Lioy; Antonio Chirico
Journal:  J Interv Card Electrophysiol       Date:  2013-03-21       Impact factor: 1.900

6.  Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study.

Authors:  Laurence Guédon-Moreau; Dominique Lacroix; Nicolas Sadoul; Jacques Clémenty; Claude Kouakam; Jean-Sylvain Hermida; Etienne Aliot; Salem Kacet
Journal:  Europace       Date:  2014-03-09       Impact factor: 5.214

7.  The changing face of monitoring and evaluation in the age of COVID-19: practitioners' field experiences from Zimbabwe.

Authors:  Thulani Dube; Siphilisiwe B Ncube; Simon Mlotshwa; Getrude N Matsika; Nelly Maonde
Journal:  Heliyon       Date:  2021-06-24

Review 8.  Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK.

Authors:  Haran Burri; Christian Sticherling; David Wright; Koji Makino; Antje Smala; Dominic Tilden
Journal:  Europace       Date:  2013-04-18       Impact factor: 5.214

Review 9.  Telemedicine and cardiac implants: what is the benefit?

Authors:  Niraj Varma; Renato Pietro Ricci
Journal:  Eur Heart J       Date:  2012-12-04       Impact factor: 29.983

Review 10.  Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.